Federal Circuit Upholds Duty-Free Treatment for Pharmaceutical Ingredient
The Court of Appeals for the Federal Circuit in an April 26 opinion upheld a Court of International Trade ruling that gave duty-free treatment to darunavir ethanolate, the active ingredient in a HIV medication from drugmaker Janssen.
Sign up for a free preview to unlock the rest of this article
Communications Daily is required reading for senior executives at top telecom corporations, law firms, lobbying organizations, associations and government agencies (including the FCC). Join them today!
Finding that the ingredient is in fact darunavir by another name, and therefore is included in Table 1 of the Pharmaceutical Appendix, the trade court ruled against the government's arguments that darunavir ethanolate has a different Chemical Abstracts Service (CAS) number, and is not a derivative listed in Table 2.